Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial

Jan B. Vermorken, Anke M.E. Claessen, Harm Van Tinteren, Helen E. Gall, Renate Ezinga, Sybren Meijer, Rik J. Scheper, Chris J.L.M. Meijer, Elizabeth Bloemena, Janet H. Ransom, Michael G. Hanna, Herbert M. Pinedo

Research output: Contribution to journalArticlepeer-review

468 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Active specific immunotherapy for stage II and stage III human colon cancer: A randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences